Medicare Enrolled
Dr. Lance Lee, M.D.
Neurology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Lance Lee is a neurology specialist in Glendale, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 2,957 Medicare services across 1,776 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $14,483 from 63 pharmaceutical and/or device companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in CA
$14,483 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,957
Medicare services
Top 18% in CA for neurology
1,776
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~148 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,060 | $99 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
534 | $141 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
529 | $66 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $93 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
144 | $141 | $200 |
| New patient office visit, complex (60-74 min) | 129 | $175 | $350 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
112 | $88 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
59 | $156 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
46 | $407 | $650 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $124 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,483
Total received (2018-2024)
Avg $2,069/year across 7 years
Top 19% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
564
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,318 (92.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$749 (5.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$416 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,321
2023
$1,650
2022
$2,418
2021
$2,500
2020
$1,656
2019
$2,229
2018
$1,708
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$432
SK Life Science, Inc.
$188
Lilly USA, LLC
$165
ABBVIE INC.
$164
ACADIA Pharmaceuticals Inc
$147
Novartis Pharmaceuticals Corporation
$132
AstraZeneca Pharmaceuticals LP
$131
Alexion Pharmaceuticals, Inc.
$121
Penumbra, Inc.
$100
Eisai Inc.
$91
ARGENX US, INC.
$90
Celgene Corporation
$72
Lundbeck LLC
$60
Teva Pharmaceuticals USA, Inc.
$58
Imperative Care, Inc
$55
Genentech USA, Inc.
$53
Boston Scientific Corporation
$51
Alnylam Pharmaceuticals Inc.
$50
Janssen Scientific Affairs, LLC
$33
MITSUBISHI TANABE PHARMA AMERICA, INC.
$30
Otsuka America Pharmaceutical, Inc.
$29
Amneal Pharmaceuticals LLC
$27
PFIZER INC.
$22
Kyowa Kirin, Inc.
$20
Top 3 companies account for 33.8% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,618
ACADIA Pharmaceuticals Inc
$819
Supernus Pharmaceuticals, Inc.
$760
Novartis Pharmaceuticals Corporation
$614
Alexion Pharmaceuticals, Inc.
$600
Abbott Laboratories
$573
ABBVIE INC.
$572
Chiesi USA, Inc.
$537
Biogen, Inc.
$520
SK Life Science, Inc.
$514
AstraZeneca Pharmaceuticals LP
$504
EMD Serono, Inc.
$474
PFIZER INC.
$438
Medtronic, Inc.
$436
DePuy Synthes Sales Inc.
$411
Viz.ai, Inc.
$335
Genentech USA, Inc.
$316
Allergan, Inc.
$293
ARGENX US, INC.
$245
Alnylam Pharmaceuticals Inc.
$235
Teva Pharmaceuticals USA, Inc.
$232
PORTOLA PHARMACEUTICALS, INC.
$223
Neurocrine Biosciences, Inc.
$211
Lilly USA, LLC
$193
Janssen Pharmaceuticals, Inc
$188
AbbVie Inc.
$185
PORTOLA PHARMACEUTICALS, LLC
$176
Amneal Pharmaceuticals LLC
$164
Stryker Corporation
$143
Janssen Scientific Affairs, LLC
$139
Biohaven Pharmaceuticals, Inc.
$117
Penumbra, Inc.
$100
Allergan Inc.
$100
Eisai Inc.
$91
GENZYME CORPORATION
$90
MDD US Operations, LLC
$83
Acorda Therapeutics, Inc
$81
Amgen Inc.
$80
Celgene Corporation
$72
Kyowa Kirin, Inc.
$71
Avanir Pharmaceuticals, Inc.
$69
LivaNova USA, Inc.
$68
Boston Scientific Corporation
$63
Lundbeck LLC
$60
Biohaven Pharmaceutical Holding Company Ltd.
$57
Medtronic USA, Inc.
$55
Imperative Care, Inc
$55
Mitsubishi Tanabe Pharma America, Inc.
$47
Horizon Therapeutics plc
$46
Sunovion Pharmaceuticals Inc.
$45
Medtronic Vascular, Inc.
$40
CHIESI USA, INC.
$39
CSL Behring
$39
E.R. Squibb & Sons, L.L.C.
$36
Adamas Pharmaceuticals, Inc.
$35
MITSUBISHI TANABE PHARMA AMERICA, INC.
$30
Otsuka America Pharmaceutical, Inc.
$29
Ceribell, Inc.
$25
Neurelis, Inc.
$24
Mylan Pharmaceuticals Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$18
Vertical Pharmaceuticals, LLC
$16
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Aimovig · Andexxa · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · CARDENE · CLEVIPREX · CLEVIPREX 50MG/100ML · Ceribell Rapid Response EEG · DRAGONFLY OPSTAR · DUOPA · Dragonfly OCT · ELIQUIS · EMBOGUARD · EMBOTRAP II Revascularization Device · EMGALITY · ENTRESTO · Enterprise 2 · GENERAL - DBS · GILENYA · GOCOVRI · Glatiramer Acetate · INBRIJA · INFINITY · INGREZZA · ISENTRESS · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Kcentra · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · Penumbra System · QULIPTA · RADICAVA · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SIGNIA · SOLIRIS · SPECTRA GALAXY G3 MIN · SYPHONTRAK · Soliris · TECFIDERA · TREVO · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Viz.AI LVO · WAINUA · WaveWriter Alpha Prime 16 · XADAGO · XARELTO · XCOPRI · ZEPOSIA · ZOOM 88-T LARGE DISTAL PLATFORM · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
535
Per 100K population
5.4
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Lee performed 1,060 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $14,483 from 63 companies across 564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other neurologists in Glendale?
Dr. Lee's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Glendale
Browse neurologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology